2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-

2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)- Struktur
1626413-47-5
CAS-Nr.
1626413-47-5
Englisch Name:
2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-
Synonyma:
2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-
CBNumber:
CB610200753
Summenformel:
C50H70N6O13
Molgewicht:
963.12
MOL-Datei:
Mol file

2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)- Eigenschaften

Siedepunkt:
1023.0±75.0 °C(Predicted)
Dichte
1.30±0.1 g/cm3(Predicted)
pka
13.90±0.70(Predicted)

Sicherheit

2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)- Chemische Eigenschaften,Einsatz,Produktion Methoden

2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Wuhan Dingxintong Pharmaceutical Co. , Ltd. 027-027-52344656 15871722230
15871722230@163.com China 4220 58

  • 2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,14(1H,7H)-trione, 10-[[2-O-benzoyl-3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4-ethyldecahydro-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[4-[4-(3-nitrophenyl)-1H-1,2,3-triazol-1-yl]butyl]-, (3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-
  • 1626413-47-5
  • C50H70N6O13
Copyright 2019 © ChemicalBook. All rights reserved